The role of RhoC in malignant tumor invasion, metastasis and targeted therapy
Related Experiment Video
Updated: Feb 27, 2026

A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
Xue Guan1, Shuo Chen1, Yang Zhao2
1Department of Gynecology, The First Affiliated Hospital of China Medical University, Shenyang, China.
Abstract:
As an important member of the RhoGTPase family, RhoC has various biological functions, such as regulating cytoskeleton reorganization, influencing cell adhesion, and migration. During recent decades, RhoC has been proven to be involved in the invasion and metastasis of malignant tumor and is thus a promising target of tumor therapy. This review focuses on the molecular mechanism of RhoC in invasion and metastasis of malignant tumors, as well as its research prospects as a potential target for tumor therapy.
Insights
RhoC, a Rho GTPase, regulates cell movement and is crucial in malignant tumor invasion and metastasis. Targeting RhoC offers a promising strategy for novel cancer therapies.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- RhoC is a key regulator of the cytoskeleton, cell adhesion, and migration.
- RhoC plays a significant role in the invasion and metastasis of malignant tumors.
- Understanding RhoC's function is vital for developing effective cancer treatments.
Purpose of the Study:
- To review the molecular mechanisms underlying RhoC's role in tumor invasion and metastasis.
- To explore the therapeutic potential of RhoC as a target for cancer treatment.
Main Methods:
- Literature review of studies on RhoC.
- Analysis of molecular pathways involving RhoC in cancer.
- Evaluation of current and prospective therapeutic strategies targeting RhoC.
Main Results:
- RhoC influences cytoskeleton dynamics, promoting cell motility and invasion.
- Aberrant RhoC expression is linked to advanced tumor stages and poor prognosis.
- Several therapeutic approaches targeting RhoC are under investigation.
Conclusions:
- RhoC is a critical mediator of cancer cell invasion and metastasis.
- Targeting RhoC presents a promising avenue for anti-cancer drug development.
- Further research into RhoC's mechanisms and therapeutic targeting is warranted.
More Related Videos
12:03Multi-photon Imaging of Tumor Cell Invasion in an Orthotopic Mouse Model of Oral Squamous Cell Carcinoma
Published on: July 25, 2011
09:44Generation of Organ-conditioned Media and Applications for Studying Organ-specific Influences on Breast Cancer Metastatic Behavior
Published on: June 13, 2016
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Mitogens and the Cell Cycle
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
The Tumor Microenvironment
Abnormal Proliferation